Search research articles
Contact Us
Filters
Showing results (311-320 of 321) with videos related to
Page
of 33
Sort By:
Targeted Oncology
|
January 12, 2022
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China
Hai-Yan Tu, Jifeng Feng, Meiqi Shi, et al.
JAMA Oncology
|
June 13, 2024
Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial
Song Dong, Zhen Wang, Jia-Tao Zhang, et al.
Cancer Cell
|
October 10, 2023
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients
Yi Pan, Jia-Tao Zhang, Xuan Gao, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 9, 2021
Corrigendum to "Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions" [Lung Cancer 159 (2021) 66-73]
Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Cell Reports
|
August 8, 2024
Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC
Yang-Si Li, Wen-Pu Lai, Kai Yin, et al.
Nature Medicine
|
July 24, 2023
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial
Si-Yang Maggie Liu, Hai-Yan Tu, Xue-Wu Wei, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2025
Cellular dynamics in cerebrospinal fluid unveils the key regulators of intracranial response to immune checkpoint inhibitors in NSCLC brain metastases
Yang-Si Li, Wenpu Lai, Kai Yin, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 26, 2021
Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions
Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Nature Medicine
|
February 27, 2025
Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases
Mei-Mei Zheng, Qing Zhou, Hua-Jun Chen, et al.
Cancer Discovery
|
March 28, 2020
HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung Cancers
Bob T Li, Flavia Michelini, Sandra Misale, et al.
Page
of 33
Search research articles
Search
Showing results (311-320 of 321) with videos related to
Sort By:
Page
of 33
Targeted Oncology
|
January 12, 2022
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China
Hai-Yan Tu, Jifeng Feng, Meiqi Shi, et al.
JAMA Oncology
|
June 13, 2024
Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial
Song Dong, Zhen Wang, Jia-Tao Zhang, et al.
Cancer Cell
|
October 10, 2023
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients
Yi Pan, Jia-Tao Zhang, Xuan Gao, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 9, 2021
Corrigendum to "Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions" [Lung Cancer 159 (2021) 66-73]
Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Cell Reports
|
August 8, 2024
Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC
Yang-Si Li, Wen-Pu Lai, Kai Yin, et al.
Nature Medicine
|
July 24, 2023
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial
Si-Yang Maggie Liu, Hai-Yan Tu, Xue-Wu Wei, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2025
Cellular dynamics in cerebrospinal fluid unveils the key regulators of intracranial response to immune checkpoint inhibitors in NSCLC brain metastases
Yang-Si Li, Wenpu Lai, Kai Yin, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 26, 2021
Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions
Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Nature Medicine
|
February 27, 2025
Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases
Mei-Mei Zheng, Qing Zhou, Hua-Jun Chen, et al.
Cancer Discovery
|
March 28, 2020
HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung Cancers
Bob T Li, Flavia Michelini, Sandra Misale, et al.
Page
of 33